• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention.

出版信息

MMWR Recomm Rep. 1994 May 20;43(RR-8):1-17.

PMID:8183226
Abstract

Although previous recommendations for preventing transmission of human immunodeficiency virus (HIV) through transplantation of human tissue and organs have markedly reduced the risk for this type of transmission, a case of HIV transmission from a screened, antibody-negative donor to several recipients raised questions about the need for additional federal oversight of transplantation of organs and tissues. A working group formed by the Public Health Service (PHS) in 1991 to address these issues concluded that further recommendations should be made to reduce the already low risk of HIV transmission by transplantation of organs and tissues. In revising these recommendations, the PHS sought assistance from public and private health professionals and representatives of transplant, public health, and other organizations. The revised guidelines address issues such as donor screening, testing, and exclusionary criteria; quarantine of tissue from living donors; inactivation or elimination of infectious organisms in organs and tissues before transplantation; timely detection, reporting, and tracking of potentially infected tissues, organs, and recipients; and recall of stored tissues from donors found after donation to have been infected. Factors considered in the development of these guidelines include differences between the screening of living and cadaveric donors; time constraints due to organ/tissue viability that may preclude performing certain screening procedures; differences in the risk of HIV transmission from various organs and tissues; differences between systems for procuring and distributing organs and tissues; the effect of screening practices on the limited availability of organs and some tissues; and the benefit of the transplant to the recipient.

摘要

相似文献

1
Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention.
MMWR Recomm Rep. 1994 May 20;43(RR-8):1-17.
2
Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.实体器官移植中传染病供体器官传播风险增加的利用:疾病传播与安全性的回顾性分析
Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12791. Epub 2017 Nov 3.
3
Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.评估实体器官捐献者和监测人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒感染的移植受者-美国卫生与公众服务部 2020 年指南。
MMWR Recomm Rep. 2020 Jun 26;69(4):1-16. doi: 10.15585/mmwr.rr6904a1.
4
Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor.1型人类免疫缺陷病毒从血清学阴性的器官和组织供体的传播。
N Engl J Med. 1992 Mar 12;326(11):726-32. doi: 10.1056/NEJM199203123261102.
5
Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor.丙型肝炎病毒从抗体阴性供体传播给多个器官和组织接受者。
Ann Intern Med. 2005 Nov 1;143(9):648-54. doi: 10.7326/0003-4819-143-9-200511010-00008.
6
Prevention of transmission of HIV by organ and tissue transplantation. HIV testing protocol and a proposal for recommendations concerning donor selection.通过器官和组织移植预防艾滋病毒传播。艾滋病毒检测方案及关于供体选择建议的提案。
Transpl Int. 1993 May;6(3):165-72. doi: 10.1007/BF00336363.
7
Screening recipients of increased-risk donor organs: a survey of transplant infectious diseases physician practices.对高风险供体器官受者进行筛查:移植传染病医生实践调查
Transpl Infect Dis. 2013 Oct;15(5):545-9. doi: 10.1111/tid.12121. Epub 2013 Jul 31.
8
A consolidated biovigilance system for blood, tissue and organs: one size does not fit all.血液、组织和器官综合生物监测系统:一刀切并不合适。
Am J Transplant. 2012 May;12(5):1099-101. doi: 10.1111/j.1600-6143.2011.03907.x. Epub 2012 Apr 9.
9
Impact of US Public Health Service increased risk deceased donor designation on organ utilization.美国公共卫生服务署提高死亡风险供体指定对器官利用的影响。
Am J Transplant. 2019 Sep;19(9):2560-2569. doi: 10.1111/ajt.15388. Epub 2019 May 3.
10
Policy statement--pediatric organ donation and transplantation.政策声明——儿科器官捐献与移植。
Pediatrics. 2010 Apr;125(4):822-8. doi: 10.1542/peds.2010-0081. Epub 2010 Mar 29.

引用本文的文献

1
Application of artificial intelligence and machine learning in lung transplantation: a comprehensive review.人工智能和机器学习在肺移植中的应用:综述
Front Digit Health. 2025 May 1;7:1583490. doi: 10.3389/fdgth.2025.1583490. eCollection 2025.
2
Real-world data to improve organ and tissue donation policies: lessons learned from the tissue and organ donor epidemiology study.真实世界数据改善器官和组织捐献政策:从组织和器官捐献者流行病学研究中汲取的经验教训。
Health Res Policy Syst. 2024 Nov 12;22(1):152. doi: 10.1186/s12961-024-01237-0.
3
Deceased Organ Donor HTLV Screening Practices Postelimination of Universal Screening in the United States.
美国取消普遍筛查后已故器官捐献者的人类嗜T淋巴细胞病毒筛查实践
Transplant Direct. 2024 Sep 17;10(10):e1707. doi: 10.1097/TXD.0000000000001707. eCollection 2024 Oct.
4
Identification of HIV infection in two solid organ recipients three years after transplantation.移植后三年两名实体器官受者的 HIV 感染鉴定。
Biomedica. 2024 Aug 29;44(3):294-304. doi: 10.7705/biomedica.7029.
5
Consent to organ offers from public health service "Increased Risk" donors decreases time to transplant and waitlist mortality.同意从公共卫生服务机构的“高风险”供体中获取器官,可以缩短移植和等待名单上的死亡率所需的时间。
BMC Med Ethics. 2022 Mar 5;23(1):20. doi: 10.1186/s12910-022-00757-0.
6
Donor Characteristics and Recipient Outcomes After Heart Transplantation in Adult Congenital Heart Disease.成人先天性心脏病心脏移植后的供体特征和受体结局。
J Am Heart Assoc. 2021 Jul 20;10(14):e020248. doi: 10.1161/JAHA.120.020248. Epub 2021 Jul 9.
7
Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.评估实体器官捐献者和监测人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒感染的移植受者-美国卫生与公众服务部 2020 年指南。
MMWR Recomm Rep. 2020 Jun 26;69(4):1-16. doi: 10.15585/mmwr.rr6904a1.
8
Impact of deceased donor multidrug-resistant bacterial organisms on organ utilization.供体来源多重耐药菌对器官利用的影响。
Am J Transplant. 2020 Sep;20(9):2559-2566. doi: 10.1111/ajt.15830. Epub 2020 Mar 12.
9
Increased-risk donors and solid organ transplantation: current practices and opportunities for improvement.高风险捐赠者与实体器官移植:当前实践与改进机遇
Curr Opin Organ Transplant. 2020 Apr;25(2):139-143. doi: 10.1097/MOT.0000000000000735.
10
Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ.使用机器学习来估计接受疾病传播风险增加的心脏、肝脏或肺的患者与等待标准器官的患者的生存曲线。
Transpl Infect Dis. 2019 Dec;21(6):e13181. doi: 10.1111/tid.13181. Epub 2019 Oct 9.